Anthem, Inc. (NASDAQ:ANTX – Get Free Report) Director Robin Shane Readnour sold 10,019 shares of the firm’s stock in a transaction on Tuesday, September 8th. The stock was sold at an average price of $6.02, for a total value of $60,314.38. Following the completion of the transaction, the director directly owned 557,990 shares in the company, valued at approximately $3,359,099.80. This represents a 1.76% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.
Robin Shane Readnour also recently made the following trade(s):
- On Thursday, September 3rd, Robin Shane Readnour sold 6,100 shares of Anthem stock. The shares were sold at an average price of $6.07, for a total value of $37,027.00.
- On Monday, August 17th, Robin Shane Readnour sold 35,402 shares of Anthem stock. The stock was sold at an average price of $6.01, for a total value of $212,766.02.
Anthem Stock Up 1.5%
Shares of ANTX opened at $5.98 on Wednesday. The business has a 50-day simple moving average of $5.33 and a two-hundred day simple moving average of $4.41. Anthem, Inc. has a 52 week low of $1.00 and a 52 week high of $7.19. The stock has a market cap of $225.66 million, a price-to-earnings ratio of -5.59 and a beta of -0.99.
Institutional Investors Weigh In On Anthem
Institutional investors and hedge funds have recently modified their holdings of the stock. ADAR1 Capital Management LLC bought a new position in shares of Anthem during the first quarter worth $47,000. OMERS ADMINISTRATION Corp bought a new stake in Anthem in the 1st quarter valued at $54,000. Velan Capital Investment Management LP bought a new stake in Anthem in the 2nd quarter valued at $194,000. Seven Fleet Capital Management LP purchased a new stake in Anthem in the 1st quarter worth $683,000. Finally, Bank of America Corp DE lifted its stake in Anthem by 2.2% in the 1st quarter. Bank of America Corp DE now owns 393,702 shares of the company’s stock worth $1,346,000 after purchasing an additional 8,390 shares in the last quarter. Institutional investors own 90.47% of the company’s stock.
Analyst Ratings Changes
A number of brokerages have recently issued reports on ANTX. Guggenheim initiated coverage on shares of Anthem in a research note on Monday, July 20th. They issued a “buy” rating and a $9.00 price objective for the company. Wall Street Zen raised shares of Anthem from a “sell” rating to a “hold” rating in a report on Sunday, June 14th. Leerink Partners upgraded Anthem from a “market perform” rating to an “outperform” rating and set a $9.00 price target for the company in a research note on Thursday, May 14th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Anthem in a report on Monday, July 6th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Anthem has an average rating of “Hold” and a consensus target price of $9.00.
View Our Latest Report on ANTX
Anthem Company Profile
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products.
See Also
- Five stocks we like better than Anthem
- Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected
- Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock
- Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement
- Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.
